These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 2544146)
1. [Oncogenes in human gastric carcinoma]. Tahara E Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146 [TBL] [Abstract][Full Text] [Related]
2. [Genetic characteristics of scirrhous gastric carcinomas]. Yokozaki H; Kuniyasu H; Yasui W; Tahara E Gan To Kagaku Ryoho; 1994 Oct; 21(14):2371-7. PubMed ID: 7944479 [TBL] [Abstract][Full Text] [Related]
3. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984 [TBL] [Abstract][Full Text] [Related]
4. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025 [TBL] [Abstract][Full Text] [Related]
5. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Volm M; Mattern J Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420 [TBL] [Abstract][Full Text] [Related]
7. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190 [TBL] [Abstract][Full Text] [Related]
8. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors. Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516 [TBL] [Abstract][Full Text] [Related]
9. Genetic pathways of two types of gastric cancer. Tahara E IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors. Shiga C; Shiga K; Hirayama K; Katayama M; Nishihira T; Mori S Anticancer Res; 1994; 14(2B):651-6. PubMed ID: 8010723 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells. Yamamoto T; Yasui W; Ochiai A; Ito H; Abe K; Yanaihara N; Tahara E Jpn J Cancer Res; 1987 Nov; 78(11):1169-74. PubMed ID: 2447046 [TBL] [Abstract][Full Text] [Related]
12. [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers]. Tahara E; Kuniyasu H; Nakayama H; Yasui W; Yokozaki H Gan To Kagaku Ryoho; 1993 Feb; 20(3):326-31. PubMed ID: 8094950 [TBL] [Abstract][Full Text] [Related]
13. Biological significance of gene amplification in carcinogenesis. Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251 [TBL] [Abstract][Full Text] [Related]
14. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224 [TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061 [TBL] [Abstract][Full Text] [Related]
17. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. Nakayama T; Ito M; Ohtsuru A; Naito S; Nakashima M; Fagin JA; Yamashita S; Sekine I Am J Pathol; 1996 Dec; 149(6):1931-9. PubMed ID: 8952528 [TBL] [Abstract][Full Text] [Related]
18. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products]. Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224 [TBL] [Abstract][Full Text] [Related]
19. Amplified genes in cancer in upper digestive tract. Yoshida T; Sakamoto H; Terada M Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412 [TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene amplification and human breast tumor phenotype. Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]